Gilat jumps on acquisition reports
The Israeli satellite networks company's share price is up sharply today on reports it might be acquired at a premium by an international company.
Clal Biotech boosted by Neon sale
Clal Biotech stands to receive shares worth $2.1 million in German company BioNTech, which is acquiring US company Neon Therapeutics.
Teva looks to China
At the JP Morgan Healthcare Conference, Teva CEO Kare Schultz said the company was on target with streamlining and debt reduction, and outlined its strategy for the Chinese market.